Southern Net News (Reporter/Tang Wenshi) April 9th, the 5th Yuncheng Tianyu Food and Drug Evaluation and Certification Technology Summit Conference and the 3rd of the 2nd Member Representative Conference with the theme of "Co-construction, Co-governance, Sharing High-quality" The second meeting was held at the Guangzhou Huangpu Science City Convention Center. This meeting was guided by the Guangdong Provincial Drug Administration, Guangzhou Huangpu District People's Government, and Development Zone Management Committee, supported by Guangzhou Huangpu District Market Supervision Administration, and hosted by Guangdong Food and Drug Evaluation and Certification Technology Association. Zhang Wei, chairman of the Chinese Society for Drug Administration, attended and delivered a speech, and Su Shengfeng, a member of the Party Leadership Group of the Guangdong Provincial Drug Administration, gave a keynote speech. Relevant supervisory departments at all levels in Guangdong Province, relevant leaders of the evaluation and certification associations, relevant pharmaceutical industry associations and representatives of many enterprises attended the event.

　　Zhang Wei said that this conference is very rare to discuss and build consensus around the hot and difficult issues in drug regulatory policies, regulations and technologies. He said that with the official issuance of the "Healthy China 2030" Planning Outline, the promotion of modernization of the drug regulatory system and capacity building, promoting the high-quality development of the pharmaceutical industry, and accelerating my country's leap from a major pharmaceutical country to a powerful pharmaceutical country is a major national decision. Strategic deployment is also the goal that the pharmaceutical industry is striving for in the new stage of development. In the face of the increasing demand for health from the people, how to stimulate the innovation vitality of pharmaceutical companies through institutional reforms, promote more new drug R&D and market, and further improve the availability of drugs for the general public, has become the focus of attention from all walks of life.

　　Su Shengfeng made a report entitled "Committed to Reform, Creating Dual Districts—Specific Practice of Comprehensive Reform of Drug Supervision in Guangdong Province". He said that the high-quality development of the industry is inseparable from the new pattern of social governance of co-construction, co-governance, and sharing. After in-depth analysis and serious thinking, the Provincial Food and Drug Administration put forward the strategic thinking and work goals of "holding high the banner of comprehensive reform of drug supervision and building a national drug quality and safety demonstration zone and a national drug industry high-quality development demonstration zone" based on the actual situation in Guangdong. Specific tasks include the issuance of the "Guangdong Province Drug Safety Responsibility Assessment Program", the establishment of a national vaccine regulatory system assessment and vaccine regulatory quality management system construction, the formulation and promulgation of the "Provincial Administration Drug Comprehensive Reform Project Management Measures", and the formulation and implementation of the "Key Projects of Biomedicine Industry, Measures for the Administration of Innovative Services in Key Enterprises and Key Regions (for Trial Implementation), introduced and implemented the “Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical and Medical Device Regulatory Innovation and Development Work Plan”, “Guangdong Province’s Implementation Plan for Promoting the High-quality Development of the Cosmetics Industry”, and formulated “Professional Professionalization” The “Implementation Plan for Building a Team of Drug Inspectors” and a series of supporting systems, and actively promote the evaluation of the national vaccine regulatory system.

　　Guangdong Food and Drug Evaluation and Certification Technology Association will report the 2020-2021 work to the participants. Adhering to the concept of polishing every precise service for the industry and the enterprise, the association focuses on professional services for review and certification, and promotes the high-quality development of the industry. In this meeting, it proposed "cultivating core competitiveness and promoting high-quality industry. The development orientation of "development"

　　The meeting also invited representatives from outstanding member companies of the association such as Guangzhou BeiGene Biopharmaceutical Co., Ltd., Sinopharm Guangzhou Co., Ltd., Sun Yat-sen University Daan Gene Co., Ltd., Perfect (China) Co., Ltd., and Guangdong Huanya Cosmetics Technology Co., Ltd. The industry's high-quality development experience and experience.

　　At the same time, the 2nd Chunhua Qiushi Quality Management Improvement Series-Excellent Quality Managers, Excellent Regulatory Affairs Managers, and Excellent Quality Improvement Projects were also announced at the meeting, in order to encourage the emergence of more quality management and regulatory affairs management elites in the pharmaceutical industry, and enhance the overall industry The level of process risk management and control promotes quality upgrading and innovative development.

　　It is reported that the Guangdong-Hong Kong-Macao Biomedicine and Biomedical Engineering Intellectual Property Forum, Cosmetics Summit, Health Food Summit, Pharmaceutical Summit, and Medical Device Summit were also held from the 9th to the 10th.